SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Mining Cholesterol
EVR 331.69+1.0%Dec 5 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Solon who wrote (125)8/24/2006 1:31:08 AM
From: E. Charters  Read Replies (2) of 356
 
It would appear that COQ10, vitamin E, and Vitamin C have a vital, mutually supportive role to play in reducing Lipid peroxidation and therefore in arterial plaque formation. How on earth then, a statin drug like Lipitor, which interferes with CoQ10 production as much as it interferes with the production of cholesterol in the liver, achieves a reduction in plaque formation, is beyond us.

Perhaps Statins such as Lipitor do not reduce lipid peroxidation, but just do not increase the rate of cholesterol plaquification much, allowing hard fibrous plaque to form but reducing the formation of soft, easily ruptured plaque. This would decrease the HA rate, but not interfere with the progress of artherosclerosis in total amount, so much as in quality.

EC<:-}
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext